CEB353Ge kit delivers critical molecular evidence for phase 3 clinical trial evaluating recombinant human serum albumin ...
FAYETTEVILLE, GA, UNITED STATES, October 19, 2026 /EINPresswire.com/ -- A new review highlights the cyclic GMP-AMP ...
A review of 5 investigational therapies with target action dates in November 2026, spanning neurology, gastroenterology, and oncology.
A case report shows tocilizumab-induced hypofibrinogenemia recurred in a rheumatoid arthritis patient even after the drug ...
New research shows that the transcription factor C/EBPβ normally restrains an inflammatory interferon and TNF-α program that, ...
For ten years Claire Lynch took heartburn pills prescribed for her stomach pain, headaches and low energy. She was told she had chronic gastritis, yet her symptoms never improved.
Transcriptional noise contributes to gene expression variability, but its origin and impact in HIV-1 latency remain ...
Lifestyle-related type 2 diabetes and associated obesity (diabesity) affect >2.5 billion people worldwide and impose nearly ...
Background The role of intrinsic tumour heterogeneity in driving organ-tropic metastasis in gastric cancer remains ...
Akeso stock reacts to new Phase III colon cancer trial Akeso (SEHK:9926) just dosed the first patient in a Phase III study of ...
ServisFirst Bancshares has produced a 63.7% gain over the past three years, yet the more pressing issue for anyone looking at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results